NYSE: NVS
Novartis Ag Stock

$85.91+0.77 (+0.9%)
Updated Jan 28, 2022
NVS Price
$85.91
Fair Value Price
N/A
Market Cap
$192.19B
52 Week Low
$79.34
52 Week High
$95.17
P/E
19.7x
P/B
3.39x
P/S
3.49x
PEG
1.03x
Dividend Yield
3.93%
Revenue
$52.39B
Earnings
$9.81B
Gross Margin
69.3%
Operating Margin
23.95%
Profit Margin
18.7%
Debt to Equity
1.13
Operating Cash Flow
$15B
Beta
0.61
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

High
Medium
Low
Industry Average (42)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NVS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NVS ($85.91) is trading below its intrinsic value of $339.80, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
NVS is good value based on its earnings relative to its share price (19.7x), compared to the US market average 33.7x)
Valuation
NVS is good value based... subscribe to Premium to read more.
Valuation
There are 34 more NVS due diligence checks available for Premium users.

NVS News

Valuation

NVS price to earnings (PE)

For valuing profitable companies with steady earnings
Company
19.7x
Industry
25.74x
Market
33.7x
NVS is good value based... subscribe to Premium to read more.
Valuation
NVS is good value based... subscribe to Premium to read more.
Valuation

NVS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.39x
Industry
5.12x
NVS is good value based... subscribe to Premium to read more.
Valuation

NVS price to earnings growth (PEG)

For valuing profitable companies with growth potential
NVS is poor value relative... subscribe to Premium to read more.
Valuation

NVS's financial health

Profit margin

Revenue
$13.4B
Net Income
$2.8B
Profit Margin
20.6%
NVS's Earnings (EBIT) of $12.55B... subscribe to Premium to read more.
Financials
NVS's profit margin has increased... subscribe to Premium to read more.
Financials

Assets to liabilities

Assets
$121.2B
Liabilities
$64.3B
Debt to equity
1.13
NVS's short-term liabilities ($29.88B) exceed... subscribe to Premium to read more.
Financials
NVS's long-term liabilities ($34.39B) exceed... subscribe to Premium to read more.
Financials
NVS's debt has increased relative... subscribe to Premium to read more.
Financials
NVS's debt to equity ratio... subscribe to Premium to read more.
Financials

Cash flow

Operating
$4.9B
Investing
-$1.2B
Financing
-$1.5B
NVS's operating cash flow ($15.19B)... subscribe to Premium to read more.
Financials

Novartis Ag Stock FAQ

What is Novartis Ag's quote symbol?

(NYSE: NVS) Novartis Ag trades on the NYSE under the ticker symbol NVS. Novartis Ag stock quotes can also be displayed as NYSE: NVS.

What is the 52 week high and low for Novartis Ag (NYSE: NVS)?

(NYSE: NVS) Novartis Ag's 52-week high was $95.17, and its 52-week low was $79.34. It is currently -9.73% from its 52-week high and 8.28% from its 52-week low.

How much is Novartis Ag stock worth today?

(NYSE: NVS) Novartis Ag currently has 2,237,091,519 outstanding shares. With Novartis Ag stock trading at $85.91 per share, the total value of Novartis Ag stock (market capitalization) is $192.19B.

Novartis Ag stock was originally listed at a price of $40.69 in Dec 31, 1997. If you had invested in Novartis Ag stock at $40.69, your return over the last 24 years would have been 111.16%, for an annualized return of 3.16% (not including any dividends or dividend reinvestments).

How much is Novartis Ag's stock price per share?

(NYSE: NVS) Novartis Ag stock price per share is $85.91 today (as of Jan 28, 2022).

What is Novartis Ag's Market Cap?

(NYSE: NVS) Novartis Ag's market cap is $192.19B, as of Jan 29, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Novartis Ag's market cap is calculated by multiplying NVS's current stock price of $85.91 by NVS's total outstanding shares of 2,237,091,519.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.